Rett Study Holds Promise for Girls Like Kira
A Phase II study (NNZ-2566) of a drug called Trofinetide has potential to minimize the symptoms of Rett syndrome. Learn more and meet one family who is dedicated to moving Rett syndrome research forward.
Stay "in the know" with our Kids Health Matters e-newsletter!
Receive the latest stories and news from Gillette delivered straight to your inbox.